 |
 |
 |
| Biobusiness Asia 2009 Conference Overview |
|
|
 |
Breakdown By Country |
| |
― More than 14 countries attended BBA 2009 in Taiwan, such as Australia,
Austria, Canada, China, Denmark, Germany, HK, Israel, Japan, Malaysia,
Netherlands, Singapore, Taiwan, U.S.A. etc. |
| |
 |
|
| |
― 286 participants attended 2009 BBA Conference,
countries including as follows: |
 |
 |
|
|
|
Attendees' Field of Expertise |
| |
| ― Industry : 52.5% |
|
― Government : 1% |
| ― Media : 13% |
― Venture Capital : 4.5% |
| ― Research Institute : 29% |
|
|
| |
 |
|
|
Conference Insights |
| |
 |
| Johnsee Lee, chairman of the 2009 BBA conference organizing committee and the president of Industrial Technology Research Institute, addressed in the opening ceremony. |
|
 |
| Business to business session in the second day afternoon conference. |
|
|
|
| |
 |
| BioBusiness Asia 2009 Opening Ceremony. The conference aims to serve as a platform to foster international collaboration for biotech industry and to explore opportunities discovering potential partners. Participants from left to right: Wu Ming-ji, head of department of Industrial Technology under Ministry of Economic Affairs; Wan Chi-Chao, the secretary general of the Science and Technology Advisory Group under Executive Yuan; Reenita Das, senior vice president, Frost and Sullivan; Israel Makov, chairman od Given Imaging & Netafim; Johnsee Lee, president of the Industrial Technology Research Institute; Sung Yen-jen, vice president of Department od Health; Jeff Wang, president of Development Center for Biotechnology. |
|
 |
| Successful Business Model and Strategy, the second-day morning session addressing innovative business models in biotech industry to overcome the recent economic recession. Participants from left to right: Jeng Her, CEO, Protevo Biotech; Tony Bishop, NZ Venture Capital Association; Frank Grams, Executive Director, Roche Pharma Partnering, Asia; Tomas Landh, Director, Novo Nordisk A/S; Ming-Chu Hsu, Founder, Chairman & CEO, TaiGen Biotechnology; Axel Polack, General Partner, TVM Capital; Dalia Cohen, Chief Scientific Officer, Rosetta Genomics. |
|
|
|
| |
 |
| Investor Forum: Exploring Trends, Paths and Opportunities in China, the first-day afternoon session. Pictured from left to right, George Yeh, President, Taiwan Liposome Company Ltd; Jennifer Hu, Director, Licensing & External Research, Merck Sharp & Dohme; Marietta Wu, General Manager, Greater China, Burrill & Co.; Nancy Chang, Chairman and Senior Managing Director , Asia team, OrbiMed; Frank Kung, Managing Partner, Vivo Venutres; Managing Partner, Perkins Coie LLP. |
|
 |
| Participants in BioBusiness Asia 2009. |
|
|
|
|
One-on-One Meeting Summary |
| |
| ― Total presenting company number : 24 |
| ― Match making company number : 63 |
| ― Total number of one-on-one meetings: 153 |
|
| |
 |
| Company presentations on Business-to-Business Partnering session. |
|
 |
| Business-to-Business session: participants to meet with each other during BBA 2009. |
|
|
|
